Comparison Effect Of Atypical Long-Acting Injection With Atypical Oral Agent Only In Schizophrenia Using Nationwide Claims Data
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1394
https://www.valueinhealthjournal.com/article/S1098-3015(16)01462-5/fulltext
Section Title :
Mental Health - Clinical Outcomes Studies
Section Order :
522
First Page :
A184
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01462-5&doi=10.1016/j.jval.2016.03.1394